nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ALB—Tacrolimus—atopic dermatitis	0.104	0.221	CbGbCtD
Captopril—ABCB1—Tacrolimus—atopic dermatitis	0.0546	0.116	CbGbCtD
Captopril—ALB—Prednisone—atopic dermatitis	0.0424	0.0898	CbGbCtD
Captopril—ABCB1—Loratadine—atopic dermatitis	0.04	0.0847	CbGbCtD
Captopril—CYP2D6—Loratadine—atopic dermatitis	0.0377	0.0798	CbGbCtD
Captopril—CYP2D6—Diphenhydramine—atopic dermatitis	0.0377	0.0798	CbGbCtD
Captopril—ABCB1—Methylprednisolone—atopic dermatitis	0.0366	0.0775	CbGbCtD
Captopril—MMP2—dermis—atopic dermatitis	0.0288	0.235	CbGeAlD
Captopril—MMP9—dermis—atopic dermatitis	0.025	0.205	CbGeAlD
Captopril—ABCB1—Betamethasone—atopic dermatitis	0.0238	0.0504	CbGbCtD
Captopril—ABCB1—Prednisolone—atopic dermatitis	0.0235	0.0497	CbGbCtD
Captopril—ABCB1—Hydrocortisone—atopic dermatitis	0.0222	0.0471	CbGbCtD
Captopril—ABCB1—Prednisone—atopic dermatitis	0.0222	0.047	CbGbCtD
Captopril—ABCB1—Dexamethasone—atopic dermatitis	0.0138	0.0293	CbGbCtD
Captopril—CYP2D6—Dexamethasone—atopic dermatitis	0.013	0.0276	CbGbCtD
Captopril—MMP2—skin epidermis—atopic dermatitis	0.0121	0.099	CbGeAlD
Captopril—MMP9—skin epidermis—atopic dermatitis	0.0105	0.0861	CbGeAlD
Captopril—REN—neck—atopic dermatitis	0.00631	0.0515	CbGeAlD
Captopril—MMP2—neck—atopic dermatitis	0.0058	0.0474	CbGeAlD
Captopril—MMP9—neck—atopic dermatitis	0.00504	0.0412	CbGeAlD
Captopril—F2—neck—atopic dermatitis	0.0044	0.036	CbGeAlD
Captopril—MMP2—skin of body—atopic dermatitis	0.00375	0.0307	CbGeAlD
Captopril—LTA4H—head—atopic dermatitis	0.00345	0.0282	CbGeAlD
Captopril—MMP9—skin of body—atopic dermatitis	0.00326	0.0267	CbGeAlD
Captopril—ACE—neck—atopic dermatitis	0.00269	0.022	CbGeAlD
Captopril—REN—head—atopic dermatitis	0.00266	0.0218	CbGeAlD
Captopril—MMP2—head—atopic dermatitis	0.00245	0.02	CbGeAlD
Captopril—MMP9—head—atopic dermatitis	0.00213	0.0174	CbGeAlD
Captopril—F2—head—atopic dermatitis	0.00186	0.0152	CbGeAlD
Captopril—ACE—head—atopic dermatitis	0.00114	0.00928	CbGeAlD
Captopril—MMP2—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.000893	0.12	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Desonide—atopic dermatitis	0.000611	0.0821	CbGdCrCtD
Captopril—MMP2—Betamethasone—Desonide—atopic dermatitis	0.000611	0.0821	CbGdCrCtD
Captopril—CYP2D6—head—atopic dermatitis	0.000556	0.00454	CbGeAlD
Captopril—MMP9—AGE/RAGE pathway—NFKBIA—atopic dermatitis	0.000504	0.00308	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ADSL—atopic dermatitis	0.000495	0.00303	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL4—atopic dermatitis	0.000493	0.00302	CbGpPWpGaD
Captopril—MMP2—Betamethasone—Fluocinonide—atopic dermatitis	0.00049	0.0658	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Fluocinonide—atopic dermatitis	0.00049	0.0658	CbGdCrCtD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—atopic dermatitis	0.000489	0.00299	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—MAPK8—atopic dermatitis	0.000482	0.00295	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CXCL10—atopic dermatitis	0.000481	0.00295	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000476	0.00291	CbGpPWpGaD
Captopril—MMP2—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000476	0.0639	CbGdCrCtD
Captopril—MMP2—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000476	0.0639	CbGdCrCtD
Captopril—MMP9—Matrix Metalloproteinases—TNF—atopic dermatitis	0.00047	0.00288	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atopic dermatitis	0.000469	0.00287	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000459	0.00281	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—CASP8—atopic dermatitis	0.000454	0.00278	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—MAPK8—atopic dermatitis	0.000454	0.00278	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—TNF—atopic dermatitis	0.000446	0.00273	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000441	0.0027	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—GLB1—atopic dermatitis	0.00044	0.0027	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—CMA1—atopic dermatitis	0.000439	0.00269	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—BDNF—atopic dermatitis	0.000432	0.00265	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000432	0.00264	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—GLB1—atopic dermatitis	0.000413	0.00253	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000409	0.0025	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL4—atopic dermatitis	0.000401	0.00246	CbGpPWpGaD
Captopril—ABCB1—head—atopic dermatitis	0.0004	0.00327	CbGeAlD
Captopril—MMP2—Dexamethasone—Mometasone—atopic dermatitis	0.00038	0.051	CbGdCrCtD
Captopril—MMP2—Betamethasone—Mometasone—atopic dermatitis	0.00038	0.051	CbGdCrCtD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000376	0.00231	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—GLB1—atopic dermatitis	0.000371	0.00227	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IFNG—atopic dermatitis	0.000368	0.00226	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—CXCL8—atopic dermatitis	0.000368	0.00225	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000367	0.00225	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000367	0.00224	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—IL6—atopic dermatitis	0.00036	0.0022	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000359	0.0022	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—TNF—atopic dermatitis	0.000359	0.0022	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL22—atopic dermatitis	0.000349	0.00214	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CXCL8—atopic dermatitis	0.000343	0.0021	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—IL6—atopic dermatitis	0.000336	0.00206	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL2—atopic dermatitis	0.000327	0.00201	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000327	0.002	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000324	0.00199	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—NPS—atopic dermatitis	0.000324	0.00199	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—atopic dermatitis	0.000321	0.00196	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00032	0.00196	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00032	0.00196	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00032	0.00196	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—MAPK8—atopic dermatitis	0.000316	0.00193	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000314	0.00192	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CMA1—atopic dermatitis	0.000313	0.00191	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000312	0.00191	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL27—atopic dermatitis	0.000311	0.00191	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atopic dermatitis	0.000308	0.00189	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—CD4—atopic dermatitis	0.000308	0.00188	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	0.000305	0.00187	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IFNG—atopic dermatitis	0.000298	0.00183	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000296	0.00181	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00029	0.00178	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00029	0.00178	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—IL6—atopic dermatitis	0.00029	0.00177	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000285	0.00175	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CMA1—atopic dermatitis	0.000281	0.00172	CbGpPWpGaD
Captopril—Fatigue—Tacrolimus—atopic dermatitis	0.000279	0.00119	CcSEcCtD
Captopril—F2—GPCR ligand binding—CCL17—atopic dermatitis	0.000279	0.00171	CbGpPWpGaD
Captopril—Diarrhoea—Mometasone—atopic dermatitis	0.000279	0.00119	CcSEcCtD
Captopril—Constipation—Tacrolimus—atopic dermatitis	0.000277	0.00118	CcSEcCtD
Captopril—Weight decreased—Dexamethasone—atopic dermatitis	0.000275	0.00117	CcSEcCtD
Captopril—Weight decreased—Betamethasone—atopic dermatitis	0.000275	0.00117	CcSEcCtD
Captopril—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000271	0.00115	CcSEcCtD
Captopril—Muscular weakness—Prednisone—atopic dermatitis	0.00027	0.00115	CcSEcCtD
Captopril—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000269	0.00114	CcSEcCtD
Captopril—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000269	0.00114	CcSEcCtD
Captopril—Rhinitis—Triamcinolone—atopic dermatitis	0.000269	0.00114	CcSEcCtD
Captopril—Rhinitis—Methylprednisolone—atopic dermatitis	0.000268	0.00114	CcSEcCtD
Captopril—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000267	0.00114	CcSEcCtD
Captopril—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000267	0.00114	CcSEcCtD
Captopril—Hallucination—Methylprednisolone—atopic dermatitis	0.000266	0.00113	CcSEcCtD
Captopril—F2—Folate Metabolism—IL1B—atopic dermatitis	0.000266	0.00163	CbGpPWpGaD
Captopril—Pharyngitis—Triamcinolone—atopic dermatitis	0.000266	0.00113	CcSEcCtD
Captopril—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000265	0.00113	CcSEcCtD
Captopril—F2—Folate Metabolism—IL2—atopic dermatitis	0.000265	0.00162	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000264	0.00162	CbGpPWpGaD
Captopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00026	0.00159	CbGpPWpGaD
Captopril—Pancreatitis—Prednisone—atopic dermatitis	0.000259	0.0011	CcSEcCtD
Captopril—Vomiting—Mometasone—atopic dermatitis	0.000259	0.0011	CcSEcCtD
Captopril—Rash—Mometasone—atopic dermatitis	0.000257	0.00109	CcSEcCtD
Captopril—Dermatitis—Mometasone—atopic dermatitis	0.000257	0.00109	CcSEcCtD
Captopril—Abdominal pain—Tacrolimus—atopic dermatitis	0.000256	0.00109	CcSEcCtD
Captopril—Body temperature increased—Tacrolimus—atopic dermatitis	0.000256	0.00109	CcSEcCtD
Captopril—Headache—Mometasone—atopic dermatitis	0.000255	0.00109	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000254	0.00155	CbGpPWpGaD
Captopril—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000253	0.00108	CcSEcCtD
Captopril—ALB—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.000248	0.00152	CbGpPWpGaD
Captopril—Neutropenia—Prednisone—atopic dermatitis	0.000247	0.00105	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000244	0.00149	CbGpPWpGaD
Captopril—Erectile dysfunction—Prednisone—atopic dermatitis	0.000244	0.00104	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—IFNG—atopic dermatitis	0.000243	0.00149	CbGpPWpGaD
Captopril—Hallucination—Betamethasone—atopic dermatitis	0.000242	0.00103	CcSEcCtD
Captopril—Hallucination—Dexamethasone—atopic dermatitis	0.000242	0.00103	CcSEcCtD
Captopril—Nausea—Mometasone—atopic dermatitis	0.000242	0.00103	CcSEcCtD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000241	0.00148	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000241	0.00148	CbGpPWpGaD
Captopril—MMP2—Betamethasone—Hydrocortisone—atopic dermatitis	0.00024	0.0323	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Hydrocortisone—atopic dermatitis	0.00024	0.0323	CbGdCrCtD
Captopril—Weight decreased—Prednisone—atopic dermatitis	0.000239	0.00102	CcSEcCtD
Captopril—Vision blurred—Prednisolone—atopic dermatitis	0.000239	0.00102	CcSEcCtD
Captopril—F2—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000237	0.00145	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000237	0.00145	CbGpPWpGaD
Captopril—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000235	0.001	CcSEcCtD
Captopril—Asthenia—Tacrolimus—atopic dermatitis	0.000233	0.00099	CcSEcCtD
Captopril—Angioedema—Prednisolone—atopic dermatitis	0.000232	0.000987	CcSEcCtD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000231	0.00142	CbGpPWpGaD
Captopril—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.00023	0.000979	CcSEcCtD
Captopril—Pruritus—Tacrolimus—atopic dermatitis	0.000229	0.000976	CcSEcCtD
Captopril—Malaise—Prednisolone—atopic dermatitis	0.000229	0.000974	CcSEcCtD
Captopril—Dysgeusia—Triamcinolone—atopic dermatitis	0.000228	0.000973	CcSEcCtD
Captopril—Syncope—Prednisolone—atopic dermatitis	0.000227	0.000968	CcSEcCtD
Captopril—MMP2—Betamethasone—Methylprednisolone—atopic dermatitis	0.000227	0.0305	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Methylprednisolone—atopic dermatitis	0.000227	0.0305	CbGdCrCtD
Captopril—Angioedema—Hydrocortisone—atopic dermatitis	0.000226	0.000964	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—CXCL8—atopic dermatitis	0.000226	0.00138	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL11—atopic dermatitis	0.000225	0.00138	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000225	0.00138	CbGpPWpGaD
Captopril—Malaise—Hydrocortisone—atopic dermatitis	0.000223	0.000951	CcSEcCtD
Captopril—MMP2—Betamethasone—Dexamethasone—atopic dermatitis	0.000223	0.03	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Betamethasone—atopic dermatitis	0.000223	0.03	CbGdCrCtD
Captopril—Loss of consciousness—Prednisolone—atopic dermatitis	0.000223	0.000949	CcSEcCtD
Captopril—F2—Hemostasis—KIF3A—atopic dermatitis	0.000223	0.00136	CbGpPWpGaD
Captopril—Syncope—Hydrocortisone—atopic dermatitis	0.000222	0.000946	CcSEcCtD
Captopril—Diarrhoea—Tacrolimus—atopic dermatitis	0.000222	0.000944	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000218	0.00134	CbGpPWpGaD
Captopril—MMP2—Betamethasone—Triamcinolone—atopic dermatitis	0.000218	0.0293	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Triamcinolone—atopic dermatitis	0.000218	0.0293	CbGdCrCtD
Captopril—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000218	0.000927	CcSEcCtD
Captopril—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000216	0.000921	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—IL1B—atopic dermatitis	0.000216	0.00133	CbGpPWpGaD
Captopril—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000216	0.000919	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—IL2—atopic dermatitis	0.000216	0.00132	CbGpPWpGaD
Captopril—Alopecia—Dexamethasone—atopic dermatitis	0.000215	0.000915	CcSEcCtD
Captopril—Alopecia—Betamethasone—atopic dermatitis	0.000215	0.000915	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000215	0.00132	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000215	0.00132	CbGpPWpGaD
Captopril—Dizziness—Tacrolimus—atopic dermatitis	0.000214	0.000912	CcSEcCtD
Captopril—Discomfort—Prednisolone—atopic dermatitis	0.000213	0.000908	CcSEcCtD
Captopril—Angioedema—Triamcinolone—atopic dermatitis	0.000213	0.000907	CcSEcCtD
Captopril—Angioedema—Methylprednisolone—atopic dermatitis	0.000213	0.000905	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000211	0.00129	CbGpPWpGaD
Captopril—Myalgia—Hydrocortisone—atopic dermatitis	0.000211	0.000898	CcSEcCtD
Captopril—Hallucination—Prednisone—atopic dermatitis	0.000211	0.000897	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000211	0.00129	CbGpPWpGaD
Captopril—Malaise—Triamcinolone—atopic dermatitis	0.00021	0.000896	CcSEcCtD
Captopril—Malaise—Methylprednisolone—atopic dermatitis	0.00021	0.000894	CcSEcCtD
Captopril—Syncope—Triamcinolone—atopic dermatitis	0.000209	0.000891	CcSEcCtD
Captopril—F2—Metabolism of proteins—GLB1—atopic dermatitis	0.000209	0.00128	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000209	0.00128	CbGpPWpGaD
Captopril—Syncope—Methylprednisolone—atopic dermatitis	0.000209	0.000889	CcSEcCtD
Captopril—Discomfort—Hydrocortisone—atopic dermatitis	0.000208	0.000887	CcSEcCtD
Captopril—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000207	0.000881	CcSEcCtD
Captopril—MMP2—Betamethasone—Prednisone—atopic dermatitis	0.000207	0.0278	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisone—atopic dermatitis	0.000207	0.0278	CbGdCrCtD
Captopril—Vomiting—Tacrolimus—atopic dermatitis	0.000206	0.000877	CcSEcCtD
Captopril—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000205	0.000873	CcSEcCtD
Captopril—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000205	0.000871	CcSEcCtD
Captopril—Rash—Tacrolimus—atopic dermatitis	0.000204	0.00087	CcSEcCtD
Captopril—Dermatitis—Tacrolimus—atopic dermatitis	0.000204	0.000869	CcSEcCtD
Captopril—Shock—Prednisolone—atopic dermatitis	0.000204	0.000867	CcSEcCtD
Captopril—Cough—Triamcinolone—atopic dermatitis	0.000204	0.000867	CcSEcCtD
Captopril—Headache—Tacrolimus—atopic dermatitis	0.000203	0.000864	CcSEcCtD
Captopril—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000202	0.000861	CcSEcCtD
Captopril—Tachycardia—Prednisolone—atopic dermatitis	0.000202	0.00086	CcSEcCtD
Captopril—MMP2—Betamethasone—Prednisolone—atopic dermatitis	0.000202	0.0271	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisolone—atopic dermatitis	0.000202	0.0271	CbGdCrCtD
Captopril—Shock—Hydrocortisone—atopic dermatitis	0.000199	0.000847	CcSEcCtD
Captopril—Myalgia—Triamcinolone—atopic dermatitis	0.000199	0.000846	CcSEcCtD
Captopril—Myalgia—Methylprednisolone—atopic dermatitis	0.000198	0.000844	CcSEcCtD
Captopril—Arthralgia—Methylprednisolone—atopic dermatitis	0.000198	0.000844	CcSEcCtD
Captopril—Tachycardia—Hydrocortisone—atopic dermatitis	0.000197	0.00084	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000197	0.00121	CbGpPWpGaD
Captopril—Flushing—Prednisone—atopic dermatitis	0.000197	0.000837	CcSEcCtD
Captopril—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000196	0.000836	CcSEcCtD
Captopril—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000196	0.000836	CcSEcCtD
Captopril—Discomfort—Triamcinolone—atopic dermatitis	0.000196	0.000835	CcSEcCtD
Captopril—Discomfort—Methylprednisolone—atopic dermatitis	0.000196	0.000834	CcSEcCtD
Captopril—ALB—Folate Metabolism—IL4—atopic dermatitis	0.000196	0.0012	CbGpPWpGaD
Captopril—Dry mouth—Triamcinolone—atopic dermatitis	0.000194	0.000827	CcSEcCtD
Captopril—Angioedema—Dexamethasone—atopic dermatitis	0.000193	0.000823	CcSEcCtD
Captopril—Angioedema—Betamethasone—atopic dermatitis	0.000193	0.000823	CcSEcCtD
Captopril—F2—Folate Metabolism—TNF—atopic dermatitis	0.000193	0.00118	CbGpPWpGaD
Captopril—Anorexia—Hydrocortisone—atopic dermatitis	0.000193	0.000821	CcSEcCtD
Captopril—Nausea—Tacrolimus—atopic dermatitis	0.000193	0.00082	CcSEcCtD
Captopril—MMP9—AP-1 transcription factor network—IL6—atopic dermatitis	0.000192	0.00118	CbGpPWpGaD
Captopril—Confusional state—Methylprednisolone—atopic dermatitis	0.000192	0.000815	CcSEcCtD
Captopril—F2—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000191	0.00117	CbGpPWpGaD
Captopril—Malaise—Dexamethasone—atopic dermatitis	0.000191	0.000813	CcSEcCtD
Captopril—Malaise—Betamethasone—atopic dermatitis	0.000191	0.000813	CcSEcCtD
Captopril—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.00019	0.000811	CcSEcCtD
Captopril—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.00019	0.000809	CcSEcCtD
Captopril—Syncope—Dexamethasone—atopic dermatitis	0.00019	0.000808	CcSEcCtD
Captopril—Syncope—Betamethasone—atopic dermatitis	0.00019	0.000808	CcSEcCtD
Captopril—Hypotension—Hydrocortisone—atopic dermatitis	0.000189	0.000804	CcSEcCtD
Captopril—Shock—Triamcinolone—atopic dermatitis	0.000187	0.000797	CcSEcCtD
Captopril—Insomnia—Prednisolone—atopic dermatitis	0.000187	0.000797	CcSEcCtD
Captopril—Alopecia—Prednisone—atopic dermatitis	0.000187	0.000797	CcSEcCtD
Captopril—Shock—Methylprednisolone—atopic dermatitis	0.000187	0.000796	CcSEcCtD
Captopril—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000186	0.000792	CcSEcCtD
Captopril—Loss of consciousness—Betamethasone—atopic dermatitis	0.000186	0.000792	CcSEcCtD
Captopril—Paraesthesia—Prednisolone—atopic dermatitis	0.000186	0.000791	CcSEcCtD
Captopril—Tachycardia—Triamcinolone—atopic dermatitis	0.000186	0.000791	CcSEcCtD
Captopril—Tachycardia—Methylprednisolone—atopic dermatitis	0.000185	0.000789	CcSEcCtD
Captopril—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000184	0.000784	CcSEcCtD
Captopril—F2—GPCR ligand binding—CCR3—atopic dermatitis	0.000183	0.00112	CbGpPWpGaD
Captopril—Insomnia—Hydrocortisone—atopic dermatitis	0.000183	0.000779	CcSEcCtD
Captopril—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000182	0.000773	CcSEcCtD
Captopril—Myalgia—Dexamethasone—atopic dermatitis	0.00018	0.000767	CcSEcCtD
Captopril—Myalgia—Betamethasone—atopic dermatitis	0.00018	0.000767	CcSEcCtD
Captopril—F2—Hemostasis—SELE—atopic dermatitis	0.000179	0.0011	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL22—atopic dermatitis	0.000179	0.0011	CbGpPWpGaD
Captopril—Discomfort—Dexamethasone—atopic dermatitis	0.000178	0.000758	CcSEcCtD
Captopril—Discomfort—Betamethasone—atopic dermatitis	0.000178	0.000758	CcSEcCtD
Captopril—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000178	0.000758	CcSEcCtD
Captopril—Hypotension—Methylprednisolone—atopic dermatitis	0.000178	0.000756	CcSEcCtD
Captopril—F2—GPCR downstream signaling—CCL27—atopic dermatitis	0.000176	0.00108	CbGpPWpGaD
Captopril—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000176	0.000748	CcSEcCtD
Captopril—Fatigue—Hydrocortisone—atopic dermatitis	0.000174	0.000742	CcSEcCtD
Captopril—Vision blurred—Prednisone—atopic dermatitis	0.000174	0.00074	CcSEcCtD
Captopril—MMP2—Developmental Biology—PPARA—atopic dermatitis	0.000173	0.00106	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000173	0.000738	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000173	0.000737	CcSEcCtD
Captopril—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000173	0.000735	CcSEcCtD
Captopril—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000173	0.000735	CcSEcCtD
Captopril—Insomnia—Triamcinolone—atopic dermatitis	0.000172	0.000733	CcSEcCtD
Captopril—Insomnia—Methylprednisolone—atopic dermatitis	0.000172	0.000731	CcSEcCtD
Captopril—Ill-defined disorder—Prednisone—atopic dermatitis	0.000171	0.000728	CcSEcCtD
Captopril—Paraesthesia—Triamcinolone—atopic dermatitis	0.000171	0.000728	CcSEcCtD
Captopril—Feeling abnormal—Prednisolone—atopic dermatitis	0.000171	0.000726	CcSEcCtD
Captopril—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000171	0.000726	CcSEcCtD
Captopril—Anaemia—Prednisone—atopic dermatitis	0.00017	0.000725	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00017	0.00104	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—CXCL8—atopic dermatitis	0.00017	0.00104	CbGpPWpGaD
Captopril—Shock—Betamethasone—atopic dermatitis	0.00017	0.000724	CcSEcCtD
Captopril—Shock—Dexamethasone—atopic dermatitis	0.00017	0.000724	CcSEcCtD
Captopril—Dyspnoea—Triamcinolone—atopic dermatitis	0.00017	0.000723	CcSEcCtD
Captopril—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000169	0.00072	CcSEcCtD
Captopril—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000169	0.00072	CcSEcCtD
Captopril—Tachycardia—Betamethasone—atopic dermatitis	0.000169	0.000718	CcSEcCtD
Captopril—Tachycardia—Dexamethasone—atopic dermatitis	0.000169	0.000718	CcSEcCtD
Captopril—Angioedema—Prednisone—atopic dermatitis	0.000168	0.000717	CcSEcCtD
Captopril—LTA4H—Metabolism—PPARA—atopic dermatitis	0.000168	0.00103	CbGpPWpGaD
Captopril—Dyspepsia—Triamcinolone—atopic dermatitis	0.000168	0.000713	CcSEcCtD
Captopril—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000167	0.000712	CcSEcCtD
Captopril—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000167	0.000709	CcSEcCtD
Captopril—ALB—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000166	0.00102	CbGpPWpGaD
Captopril—Malaise—Prednisone—atopic dermatitis	0.000166	0.000708	CcSEcCtD
Captopril—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000165	0.000704	CcSEcCtD
Captopril—Syncope—Prednisone—atopic dermatitis	0.000165	0.000704	CcSEcCtD
Captopril—Anorexia—Betamethasone—atopic dermatitis	0.000165	0.000701	CcSEcCtD
Captopril—Anorexia—Dexamethasone—atopic dermatitis	0.000165	0.000701	CcSEcCtD
Captopril—Fatigue—Triamcinolone—atopic dermatitis	0.000164	0.000699	CcSEcCtD
Captopril—Fatigue—Methylprednisolone—atopic dermatitis	0.000164	0.000697	CcSEcCtD
Captopril—F2—GPCR ligand binding—NPS—atopic dermatitis	0.000164	0.001	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—TAC1—atopic dermatitis	0.000164	0.001	CbGpPWpGaD
Captopril—Loss of consciousness—Prednisone—atopic dermatitis	0.000162	0.00069	CcSEcCtD
Captopril—Hypotension—Betamethasone—atopic dermatitis	0.000161	0.000687	CcSEcCtD
Captopril—Hypotension—Dexamethasone—atopic dermatitis	0.000161	0.000687	CcSEcCtD
Captopril—F2—GPCR ligand binding—CXCR3—atopic dermatitis	0.00016	0.000982	CbGpPWpGaD
Captopril—Body temperature increased—Hydrocortisone—atopic dermatitis	0.00016	0.00068	CcSEcCtD
Captopril—Abdominal pain—Hydrocortisone—atopic dermatitis	0.00016	0.00068	CcSEcCtD
Captopril—F2—Signaling by GPCR—CCL27—atopic dermatitis	0.00016	0.000979	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000158	0.00097	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CMA1—atopic dermatitis	0.000158	0.00097	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000157	0.00067	CcSEcCtD
Captopril—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000157	0.00067	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—TNF—atopic dermatitis	0.000157	0.000962	CbGpPWpGaD
Captopril—Arthralgia—Prednisone—atopic dermatitis	0.000157	0.000668	CcSEcCtD
Captopril—Myalgia—Prednisone—atopic dermatitis	0.000157	0.000668	CcSEcCtD
Captopril—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000157	0.000668	CcSEcCtD
Captopril—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000157	0.000666	CcSEcCtD
Captopril—Insomnia—Dexamethasone—atopic dermatitis	0.000156	0.000665	CcSEcCtD
Captopril—Insomnia—Betamethasone—atopic dermatitis	0.000156	0.000665	CcSEcCtD
Captopril—F2—Folate Metabolism—IL6—atopic dermatitis	0.000156	0.000954	CbGpPWpGaD
Captopril—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000155	0.000661	CcSEcCtD
Captopril—Paraesthesia—Dexamethasone—atopic dermatitis	0.000155	0.00066	CcSEcCtD
Captopril—Paraesthesia—Betamethasone—atopic dermatitis	0.000155	0.00066	CcSEcCtD
Captopril—Discomfort—Prednisone—atopic dermatitis	0.000155	0.00066	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000153	0.000939	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL10—atopic dermatitis	0.000153	0.000935	CbGpPWpGaD
Captopril—Dyspepsia—Betamethasone—atopic dermatitis	0.000152	0.000647	CcSEcCtD
Captopril—Dyspepsia—Dexamethasone—atopic dermatitis	0.000152	0.000647	CcSEcCtD
Captopril—Body temperature increased—Triamcinolone—atopic dermatitis	0.000151	0.000641	CcSEcCtD
Captopril—Anaphylactic shock—Prednisone—atopic dermatitis	0.00015	0.00064	CcSEcCtD
Captopril—Abdominal pain—Methylprednisolone—atopic dermatitis	0.00015	0.000639	CcSEcCtD
Captopril—Decreased appetite—Dexamethasone—atopic dermatitis	0.00015	0.000639	CcSEcCtD
Captopril—Decreased appetite—Betamethasone—atopic dermatitis	0.00015	0.000639	CcSEcCtD
Captopril—Fatigue—Dexamethasone—atopic dermatitis	0.000149	0.000634	CcSEcCtD
Captopril—Fatigue—Betamethasone—atopic dermatitis	0.000149	0.000634	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—IL4—atopic dermatitis	0.000149	0.00091	CbGpPWpGaD
Captopril—Shock—Prednisone—atopic dermatitis	0.000148	0.00063	CcSEcCtD
Captopril—MMP9—Signaling Pathways—FCER2—atopic dermatitis	0.000148	0.000904	CbGpPWpGaD
Captopril—Tachycardia—Prednisone—atopic dermatitis	0.000147	0.000625	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000147	0.000898	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000146	0.000893	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000145	0.000891	CbGpPWpGaD
Captopril—Asthenia—Hydrocortisone—atopic dermatitis	0.000145	0.000618	CcSEcCtD
Captopril—Anorexia—Prednisone—atopic dermatitis	0.000143	0.000611	CcSEcCtD
Captopril—F2—Signaling by GPCR—CCL17—atopic dermatitis	0.000143	0.000878	CbGpPWpGaD
Captopril—Pruritus—Hydrocortisone—atopic dermatitis	0.000143	0.000609	CcSEcCtD
Captopril—Feeling abnormal—Betamethasone—atopic dermatitis	0.000142	0.000606	CcSEcCtD
Captopril—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000142	0.000606	CcSEcCtD
Captopril—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000141	0.000601	CcSEcCtD
Captopril—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000141	0.000601	CcSEcCtD
Captopril—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000138	0.000589	CcSEcCtD
Captopril—MMP9—Signaling Pathways—CCL22—atopic dermatitis	0.000137	0.00084	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000137	0.000584	CcSEcCtD
Captopril—Dizziness—Prednisolone—atopic dermatitis	0.000137	0.000583	CcSEcCtD
Captopril—Asthenia—Triamcinolone—atopic dermatitis	0.000137	0.000582	CcSEcCtD
Captopril—Abdominal pain—Betamethasone—atopic dermatitis	0.000137	0.000581	CcSEcCtD
Captopril—Body temperature increased—Betamethasone—atopic dermatitis	0.000137	0.000581	CcSEcCtD
Captopril—Body temperature increased—Dexamethasone—atopic dermatitis	0.000137	0.000581	CcSEcCtD
Captopril—Abdominal pain—Dexamethasone—atopic dermatitis	0.000137	0.000581	CcSEcCtD
Captopril—Asthenia—Methylprednisolone—atopic dermatitis	0.000136	0.00058	CcSEcCtD
Captopril—Insomnia—Prednisone—atopic dermatitis	0.000136	0.000579	CcSEcCtD
Captopril—F2—Hemostasis—IL5—atopic dermatitis	0.000136	0.000833	CbGpPWpGaD
Captopril—Paraesthesia—Prednisone—atopic dermatitis	0.000135	0.000575	CcSEcCtD
Captopril—Pruritus—Triamcinolone—atopic dermatitis	0.000135	0.000573	CcSEcCtD
Captopril—Pruritus—Methylprednisolone—atopic dermatitis	0.000134	0.000572	CcSEcCtD
Captopril—Dizziness—Hydrocortisone—atopic dermatitis	0.000134	0.000569	CcSEcCtD
Captopril—Dyspepsia—Prednisone—atopic dermatitis	0.000132	0.000564	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000132	0.000809	CbGpPWpGaD
Captopril—Decreased appetite—Prednisone—atopic dermatitis	0.000131	0.000557	CcSEcCtD
Captopril—Rash—Prednisolone—atopic dermatitis	0.000131	0.000556	CcSEcCtD
Captopril—Dermatitis—Prednisolone—atopic dermatitis	0.00013	0.000555	CcSEcCtD
Captopril—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00013	0.000553	CcSEcCtD
Captopril—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.00013	0.000794	CbGpPWpGaD
Captopril—Fatigue—Prednisone—atopic dermatitis	0.00013	0.000552	CcSEcCtD
Captopril—Headache—Prednisolone—atopic dermatitis	0.00013	0.000552	CcSEcCtD
Captopril—F2—GPCR ligand binding—CXCL10—atopic dermatitis	0.00013	0.000794	CbGpPWpGaD
Captopril—Constipation—Prednisone—atopic dermatitis	0.000129	0.000548	CcSEcCtD
Captopril—Vomiting—Hydrocortisone—atopic dermatitis	0.000129	0.000547	CcSEcCtD
Captopril—Rash—Hydrocortisone—atopic dermatitis	0.000127	0.000543	CcSEcCtD
Captopril—Dermatitis—Hydrocortisone—atopic dermatitis	0.000127	0.000542	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—IL6—atopic dermatitis	0.000127	0.000776	CbGpPWpGaD
Captopril—Headache—Hydrocortisone—atopic dermatitis	0.000127	0.000539	CcSEcCtD
Captopril—Dizziness—Triamcinolone—atopic dermatitis	0.000126	0.000536	CcSEcCtD
Captopril—Dizziness—Methylprednisolone—atopic dermatitis	0.000126	0.000535	CcSEcCtD
Captopril—Feeling abnormal—Prednisone—atopic dermatitis	0.000124	0.000528	CcSEcCtD
Captopril—Asthenia—Dexamethasone—atopic dermatitis	0.000124	0.000528	CcSEcCtD
Captopril—Asthenia—Betamethasone—atopic dermatitis	0.000124	0.000528	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000124	0.000758	CbGpPWpGaD
Captopril—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000123	0.000524	CcSEcCtD
Captopril—Nausea—Prednisolone—atopic dermatitis	0.000123	0.000524	CcSEcCtD
Captopril—MMP9—Signaling Pathways—CCL27—atopic dermatitis	0.000122	0.000749	CbGpPWpGaD
Captopril—Pruritus—Betamethasone—atopic dermatitis	0.000122	0.00052	CcSEcCtD
Captopril—Pruritus—Dexamethasone—atopic dermatitis	0.000122	0.00052	CcSEcCtD
Captopril—Vomiting—Triamcinolone—atopic dermatitis	0.000121	0.000515	CcSEcCtD
Captopril—Vomiting—Methylprednisolone—atopic dermatitis	0.000121	0.000514	CcSEcCtD
Captopril—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.00012	0.000737	CbGpPWpGaD
Captopril—Nausea—Hydrocortisone—atopic dermatitis	0.00012	0.000511	CcSEcCtD
Captopril—Rash—Triamcinolone—atopic dermatitis	0.00012	0.000511	CcSEcCtD
Captopril—Dermatitis—Triamcinolone—atopic dermatitis	0.00012	0.000511	CcSEcCtD
Captopril—Rash—Methylprednisolone—atopic dermatitis	0.00012	0.00051	CcSEcCtD
Captopril—Dermatitis—Methylprednisolone—atopic dermatitis	0.00012	0.000509	CcSEcCtD
Captopril—Headache—Triamcinolone—atopic dermatitis	0.000119	0.000508	CcSEcCtD
Captopril—Headache—Methylprednisolone—atopic dermatitis	0.000119	0.000507	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000119	0.000729	CbGpPWpGaD
Captopril—Body temperature increased—Prednisone—atopic dermatitis	0.000119	0.000506	CcSEcCtD
Captopril—Abdominal pain—Prednisone—atopic dermatitis	0.000119	0.000506	CcSEcCtD
Captopril—ALB—Folate Metabolism—IFNG—atopic dermatitis	0.000118	0.000725	CbGpPWpGaD
Captopril—Diarrhoea—Betamethasone—atopic dermatitis	0.000118	0.000503	CcSEcCtD
Captopril—Diarrhoea—Dexamethasone—atopic dermatitis	0.000118	0.000503	CcSEcCtD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000118	0.00072	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL11—atopic dermatitis	0.000116	0.000707	CbGpPWpGaD
Captopril—Dizziness—Dexamethasone—atopic dermatitis	0.000114	0.000486	CcSEcCtD
Captopril—Dizziness—Betamethasone—atopic dermatitis	0.000114	0.000486	CcSEcCtD
Captopril—F2—Signaling Pathways—FCER2—atopic dermatitis	0.000114	0.000698	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—PPARA—atopic dermatitis	0.000114	0.000697	CbGpPWpGaD
Captopril—Nausea—Triamcinolone—atopic dermatitis	0.000113	0.000481	CcSEcCtD
Captopril—Nausea—Methylprednisolone—atopic dermatitis	0.000113	0.00048	CcSEcCtD
Captopril—F2—GPCR ligand binding—CCL5—atopic dermatitis	0.000112	0.000683	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—atopic dermatitis	0.00011	0.000673	CbGpPWpGaD
Captopril—Vomiting—Dexamethasone—atopic dermatitis	0.00011	0.000468	CcSEcCtD
Captopril—Vomiting—Betamethasone—atopic dermatitis	0.00011	0.000468	CcSEcCtD
Captopril—MMP9—Signaling Pathways—CCL17—atopic dermatitis	0.00011	0.000672	CbGpPWpGaD
Captopril—Rash—Betamethasone—atopic dermatitis	0.000109	0.000464	CcSEcCtD
Captopril—Rash—Dexamethasone—atopic dermatitis	0.000109	0.000464	CcSEcCtD
Captopril—Dermatitis—Betamethasone—atopic dermatitis	0.000109	0.000463	CcSEcCtD
Captopril—Dermatitis—Dexamethasone—atopic dermatitis	0.000109	0.000463	CcSEcCtD
Captopril—Headache—Betamethasone—atopic dermatitis	0.000108	0.000461	CcSEcCtD
Captopril—Headache—Dexamethasone—atopic dermatitis	0.000108	0.000461	CcSEcCtD
Captopril—Asthenia—Prednisone—atopic dermatitis	0.000108	0.00046	CcSEcCtD
Captopril—Pruritus—Prednisone—atopic dermatitis	0.000106	0.000453	CcSEcCtD
Captopril—F2—Signaling Pathways—CCL22—atopic dermatitis	0.000106	0.000649	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	0.000106	0.000647	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL1B—atopic dermatitis	0.000106	0.000646	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL2—atopic dermatitis	0.000105	0.000644	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000105	0.000641	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000104	0.000635	CbGpPWpGaD
Captopril—Diarrhoea—Prednisone—atopic dermatitis	0.000103	0.000438	CcSEcCtD
Captopril—Nausea—Betamethasone—atopic dermatitis	0.000103	0.000437	CcSEcCtD
Captopril—Nausea—Dexamethasone—atopic dermatitis	0.000103	0.000437	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.000101	0.000617	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCR5—atopic dermatitis	0.000101	0.000616	CbGpPWpGaD
Captopril—Dizziness—Prednisone—atopic dermatitis	9.95e-05	0.000424	CcSEcCtD
Captopril—MMP9—Signaling Pathways—KIF3A—atopic dermatitis	9.77e-05	0.000599	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	9.59e-05	0.000588	CbGpPWpGaD
Captopril—Vomiting—Prednisone—atopic dermatitis	9.57e-05	0.000407	CcSEcCtD
Captopril—Rash—Prednisone—atopic dermatitis	9.49e-05	0.000404	CcSEcCtD
Captopril—Dermatitis—Prednisone—atopic dermatitis	9.48e-05	0.000403	CcSEcCtD
Captopril—F2—Signaling Pathways—CCL27—atopic dermatitis	9.44e-05	0.000578	CbGpPWpGaD
Captopril—Headache—Prednisone—atopic dermatitis	9.42e-05	0.000401	CcSEcCtD
Captopril—F2—Signaling by GPCR—CCR3—atopic dermatitis	9.42e-05	0.000577	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	9.41e-05	0.000576	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	9.4e-05	0.000576	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—NPS—atopic dermatitis	9.24e-05	0.000566	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TAC1—atopic dermatitis	9.24e-05	0.000566	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCR3—atopic dermatitis	9.06e-05	0.000555	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	8.98e-05	0.00055	CbGpPWpGaD
Captopril—Nausea—Prednisone—atopic dermatitis	8.94e-05	0.00038	CcSEcCtD
Captopril—MMP9—Signaling Pathways—CCL11—atopic dermatitis	8.84e-05	0.000541	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CMA1—atopic dermatitis	8.84e-05	0.000541	CbGpPWpGaD
Captopril—ALB—Hemostasis—KIF3A—atopic dermatitis	8.83e-05	0.000541	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—atopic dermatitis	8.61e-05	0.000527	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL5—atopic dermatitis	8.59e-05	0.000526	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL17—atopic dermatitis	8.47e-05	0.000518	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CXCL8—atopic dermatitis	8.44e-05	0.000517	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TAC1—atopic dermatitis	8.39e-05	0.000514	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—NPS—atopic dermatitis	8.39e-05	0.000514	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	8.38e-05	0.000514	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	8.35e-05	0.000511	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT6—atopic dermatitis	8.31e-05	0.000509	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCR3—atopic dermatitis	8.23e-05	0.000504	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	8.01e-05	0.00049	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.98e-05	0.000489	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2—atopic dermatitis	7.98e-05	0.000489	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	7.89e-05	0.000483	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL5—atopic dermatitis	7.8e-05	0.000478	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	7.67e-05	0.00047	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—atopic dermatitis	7.66e-05	0.000469	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—atopic dermatitis	7.62e-05	0.000466	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	7.6e-05	0.000465	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CXCL8—atopic dermatitis	7.59e-05	0.000465	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KIF3A—atopic dermatitis	7.55e-05	0.000462	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL10—atopic dermatitis	7.33e-05	0.000449	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR3—atopic dermatitis	7.2e-05	0.000441	CbGpPWpGaD
Captopril—ALB—Hemostasis—SELE—atopic dermatitis	7.12e-05	0.000436	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL11—atopic dermatitis	6.82e-05	0.000418	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CMA1—atopic dermatitis	6.82e-05	0.000418	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL10—atopic dermatitis	6.65e-05	0.000407	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TAC1—atopic dermatitis	6.42e-05	0.000393	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NPS—atopic dermatitis	6.42e-05	0.000393	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT6—atopic dermatitis	6.42e-05	0.000393	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCL5—atopic dermatitis	6.31e-05	0.000386	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCR3—atopic dermatitis	6.3e-05	0.000386	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—atopic dermatitis	6.18e-05	0.000379	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—atopic dermatitis	6.15e-05	0.000376	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.11e-05	0.000374	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	6.08e-05	0.000373	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL8—atopic dermatitis	6.08e-05	0.000372	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	6.06e-05	0.000371	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL5—atopic dermatitis	5.97e-05	0.000366	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—atopic dermatitis	5.81e-05	0.000356	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	5.78e-05	0.000354	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL5—atopic dermatitis	5.73e-05	0.000351	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.7e-05	0.000349	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR5—atopic dermatitis	5.68e-05	0.000348	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—atopic dermatitis	5.65e-05	0.000346	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR3—atopic dermatitis	5.56e-05	0.000341	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL5—atopic dermatitis	5.39e-05	0.00033	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.35e-05	0.000328	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	5.21e-05	0.000319	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—atopic dermatitis	5.19e-05	0.000318	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR5—atopic dermatitis	5.16e-05	0.000316	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL10—atopic dermatitis	5.09e-05	0.000312	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—atopic dermatitis	5e-05	0.000306	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NPS—atopic dermatitis	4.96e-05	0.000304	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TAC1—atopic dermatitis	4.96e-05	0.000304	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	4.91e-05	0.000301	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCR3—atopic dermatitis	4.86e-05	0.000298	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL5—atopic dermatitis	4.61e-05	0.000282	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL5—atopic dermatitis	4.38e-05	0.000268	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—atopic dermatitis	4.28e-05	0.000262	CbGpPWpGaD
Captopril—ALB—Metabolism—GLB1—atopic dermatitis	4.27e-05	0.000262	CbGpPWpGaD
Captopril—ALB—Metabolism—ADSL—atopic dermatitis	4.1e-05	0.000251	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NGF—atopic dermatitis	4.06e-05	0.000249	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—atopic dermatitis	4.03e-05	0.000247	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	4e-05	0.000245	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR5—atopic dermatitis	3.95e-05	0.000242	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL10—atopic dermatitis	3.93e-05	0.000241	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GLB1—atopic dermatitis	3.74e-05	0.000229	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.62e-05	0.000222	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADSL—atopic dermatitis	3.59e-05	0.00022	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GLB1—atopic dermatitis	3.53e-05	0.000216	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—atopic dermatitis	3.44e-05	0.00021	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL5—atopic dermatitis	3.38e-05	0.000207	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADSL—atopic dermatitis	3.38e-05	0.000207	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NFKBIA—atopic dermatitis	3.35e-05	0.000205	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—atopic dermatitis	3.28e-05	0.000201	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NGF—atopic dermatitis	3.13e-05	0.000192	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—atopic dermatitis	3.12e-05	0.000191	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.11e-05	0.000191	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR5—atopic dermatitis	3.05e-05	0.000187	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—atopic dermatitis	2.98e-05	0.000183	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.96e-05	0.000181	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.87e-05	0.000176	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.59e-05	0.000159	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NFKBIA—atopic dermatitis	2.58e-05	0.000158	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—atopic dermatitis	2.39e-05	0.000146	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—atopic dermatitis	2.28e-05	0.00014	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK8—atopic dermatitis	2.1e-05	0.000129	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—atopic dermatitis	2.06e-05	0.000126	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—atopic dermatitis	1.84e-05	0.000113	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—atopic dermatitis	1.76e-05	0.000108	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—atopic dermatitis	1.75e-05	0.000107	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK8—atopic dermatitis	1.62e-05	9.93e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARA—atopic dermatitis	1.39e-05	8.49e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—atopic dermatitis	1.34e-05	8.21e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARA—atopic dermatitis	1.21e-05	7.44e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.14e-05	7.01e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—atopic dermatitis	1.04e-05	6.34e-05	CbGpPWpGaD
